Skip to main content
Download PDF
Download ePub
  • Systematic review
  • Open access
  • Published:

Prevalence and genotype distribution of viral hepatitis B in Cambodia between 1990 and 2020: a systematic review and meta-analysis

Archives of Public Health volume 80, Article number: 119 (2022) Cite this article

Abstract

Background

Hepatitis B virus (HBV) infection is one of the major public health problems globally as well as in Cambodia. Continuous information on HBV infection burden is required to implement effective disease control strategies. This study aimed to determine the prevalence and genotype distribution of HBV infection in Cambodia through a systematic review with meta-analysis.

Methods

Four databases (PubMed, Web of Science, Scopus, and Google Scholar) were used to search published studies reporting either HBV prevalence or genotype distribution in Cambodia until August 21, 2020. Reviews, modeling studies, and studies conducted among Cambodian permanently living abroad were excluded. The Freeman–Tukey double arcsine transformation was implemented to achieve approximate normality. The DerSimonian and Laird method was used to compute pooled estimates based on the transformed values and their variance. Possible publication bias was assessed by the Egger test and the funnel plot.

Results

A total of 22 studies were included, covering 22,323 people. Ten studies reported HBV prevalence in the general population. The HBV infection prevalence was 4.73% (95%CI: 2.75–7.17%) in the general population and 19.87% (95%CI: 10.95–30.63%) in high-risk/co-infected groups. By sub-group analysis, the prevalence was 6.81% (95% CI: 4.43–9.66) in adults older than 15 years old, 2.37% (95% CI:0.04–7.05) in children 6–15 years old, and 2.47% (95% CI: 0.96–4.59) in children less than five years old. The prevalence of HBV infection decreased over time. Predominant HBV genotypes were genotypes C and B with 82.96% and 16.79%, respectively.

Conclusions

The decrease in HBV infection prevalence in Cambodia demonstrates the effects of national hepatitis B immunization, improved clinical hygiene, and the use of disposable devices. However, the estimated HBV prevalence among the general population indicates an intermediate endemicity level of HBV infection. Therefore, population screening and linkage to care, high vaccination coverage, health promotion, and HBV surveillance are essential to meet the WHO 2030 goal.

Peer Review reports

Background

Hepatitis B virus (HBV) infection is a major public health problem globally. The virus that causes hepatitis B can be transmitted from mother to child, direct contact with infected blood or other body fluids, sexual intercourse with an infected person, or sharing sharp instruments. In 2015, the number of people living with chronic HBV infection was estimated at 257 million, and 887 000 died mainly as the result of hepatocellular carcinoma (HCC) [1]. Therefore, at the 69th world health assembly in 2016, 194 member states committed to eliminate viral hepatitis by 2030 [2].

Cambodia is located in the World Health Organization (WHO) Western Pacific Region, which is reported to have the highest prevalence of HBV infection (6.2% of the adult population) among all WHO regions [1]. The WHO Western Pacific region bears over 45% of the global HBV burden [3]. However, the prevalence of HBV infection varies considerably among state members, ranging from 1.0% to 18.8% [3]. HBV infection is one of the public health burdens in Cambodia. Children infected with HBV before five years old are more likely to develop chronic infections [1]. Therefore, administration of the hepatitis B vaccine (Hep B) within 24 h of birth, followed by three doses of pentavalent vaccine (at 6, 10, and 14 weeks of life), have been introduced into Cambodia’s national immunization program since 2005 [4]. Prior to the implementation of Hep B vaccine, the prevalence of HBV infection was reported at 2.02% (95% CI 0.27–3.77%) among children born between 1999 to 2005 in Siem Reap province [5]. The latest large-scale nationwide study on the prevalence of HBV infection in 2017 found a prevalence of 0.56% (95% CI 0.32–0.98%) among children aged 5–7 years, and 4.39% (95% CI 3.53–5.45%) in their mothers [6].

Cambodia has made a tremendous effort to combat HBV by achieving the 2017 target of lowering the HBV prevalence among children to less than 1 percent [4]. Eliminating mother-to-child transmission is another milestone on which the government of Cambodia is focusing. Moreover, some tasks must be done to move towards the global target of hepatitis B elimination by 2030, including boosting the awareness program, prevention, and treatment strategy. To implement effective strategies, more information on HBV infection is needed. This systematic review and meta-analysis aimed to estimate the prevalence of HBV infection and its genotype distribution in Cambodia.

Methods

Literature and search strategy

Four literature databases, PubMed, Web of Science, Scopus, and Google Scholar were used, and the last search was conducted on August 21, 2020. The keywords were: hepatitis B, hepatitis B surface antigen, HBV, HBsAg, epidemiology, prevalence, seroprevalence, DNA, genotype, and Cambodia. The search was modified to match the particular structure of each database (Supplementary Table 1).

Study selection

We included all the published studies reporting HBV infection prevalence or genotype distribution among people living in Cambodia or Cambodian temporally living abroad. However, we excluded reviews, modeling studies, studies conducted among Cambodian permanently living abroad or duplicated articles that studied the same population during the same period.

All studies extracted from literature databases were reviewed independently by two reviewers (BE & PO). First, the duplicated records were removed using the Endnote reference manager. Then, the title and abstract were screened to eliminate irrelevant studies, and the full texts of potentially eligible studies were assessed for inclusion. Furthermore, the snowballing approach was used to identify additional studies. The final inclusion decision was based on consensus or by a third reviewer (AS) if no consensus was reached.

The following information was extracted independently by two reviewers (BE & PO): year of the study, year of publication, first author, study design, study population, study setting, diagnostic method, sample size, number of positive cases, and genotype distribution.

Quality assessment

The quality of each included study was assessed separately by two reviewers (BE & PO) following the Guideline of Recommendation Assessment, Development and Evaluation (GRADE) guideline [7]. The quality of evidence was classified into four categories (high, moderate, low, and very low quality).

Data management and analysis

EndNote X9 was employed to manage citations. Extracted data were recorded in Microsoft Excel and analyzed with STATA® 16, using the ‘metaprop’ package. Given that the included studies were conducted at different periods, on different population groups, and in different geographic locations, a random-effect model was employed because of the expected heterogeneity across studies [8, 9]. The Freeman–Tukey double arcsine transformation was implemented to achieve approximate normality. Then, the DerSimonian and Laird method was used to compute the pooled estimates based on the transformed values and their variance. The Wald method was then used to calculate the confidence intervals for the pooled estimates [9]. The Cochran’s Q test was used to determine heterogeneity, and the I2 index was used to quantify it. When the p-value of the Cochran’s Q test was less than 0.05, heterogeneity was considered significant. I2 of ≥ 50% was considered as substantial heterogeneity.

Among the general population, subgroup analysis was performed to minimize the heterogeneity and for group comparison. A p-value less than 0.05 was considered statistically significant.

The Egger test and funnel plot were used to assess possible publication bias.

Study guideline

This systematic review was conducted following the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines [10]. (Supplementary Table 2 and 3).

Results

General overview

A total of 663 studies were identified through database search. After removing duplicates, followed by titles and abstracts screening, 32 studies were eligible for full text and bibliography assessment. Out of them, 20 studies met the inclusion criteria, and two additional studies were included from manual citation screening. Thus, the quantitative analysis included 22 studies that covered 22,323 people. (Fig. 1). The summary of all included studies is presented in Table 1.

Fig. 1
figure 1

Flow chart of selecting published studies through database searching. At first, 663 studies were identified via databases, and 2 studies were identified via citation screening. After abstract screening and full-text assessment, 22 studies were included in the quantitative synthesis

Full size image
Table 1 Summary of the studies on prevalence or genotype of HBV in Cambodia, 1990–2020
Full size table

Seventeen studies reported only the prevalence of HBV infection [5, 6, 11,12,13,14,15,16,17,18,19,20,21,22,23,24,25], four studies reported only HBV genotype distribution [26,27,28,29], and one study reported both the prevalence and genotype distribution of HBV infection [30]. Among the studies that reported HBV prevalence, ten were conducted among the general population, and eight investigated the high-risk/co-infection population. (Table 1).

Overall prevalence estimate

Of the 18 prevalence studies, 10 studies were conducted among the general population between 1990 to 2017 [5, 6, 13, 15, 19, 21,22,23, 25, 30]. In the general population, HBV infection pooled prevalence was 4.73% (95% CI: 2.75–7.17%), ranging from 1.42% (95% CI: 1.01–1.97%) to 10.81% (95% CI: 9.13–12.77%), with large heterogeneity across studies (I2 = 99.23%, Cochran’s Q test p < 0.001). Pooled HBV infection prevalence in high risk/co-infection population between 1998 to 2017 [11, 12, 14, 16,17,18, 20, 24] was 19.87% (95% CI 10.95–30.63%), ranged from 2% (95% CI: 1.53–2.62%) to 54.07% (95% CI: 47.30–60.69%), with large heterogeneity across studies (I2 = 99.23%, Cochran’s Q test p < 0.001). (Fig. 2).

Fig. 2
figure 2

Estimated prevalence of HBV infection in Cambodia, 1990 and 2020. This figure shows the pooled prevalence of HBV infection in Cambodia in the general and high-risk/co-infection populations. The blue square presents the prevalence of HBV infection in each individual study with its 95% confidence interval. The red diamond represents the pooled prevalence of HBV infection in each population group. PLWHIV: People Living with HIV; HCC: Hepatocellular Carcinoma; HCV: Hepatitis C Virus; ALT/AST: Alanine Aminotransferase/Aspartate Aminotransferase

Full size image

Prevalence of HBV infection among the general population based on participants’ age

Nine studies provided age information of the subjects, and subgroup analysis was conducted in three age categories: less than 5 years (4 studies), 6–15 years (4 studies), > 15 years (5 studies). The estimated HBV infection prevalence in adults older than 15 years was 6.81% (95% CI 4.43–9.66%) and was higher than the other age groups (p = 0.022). (Table 2).

Table 2 Sub-group analysis of HBV prevalence among general population in Cambodia, 1990 to 2020
Full size table

Prevalence of HBV infection among the general population based on study area

Six of the ten studies on the general population were conducted exclusively in rural areas [5, 19, 21, 23, 25, 30]. Two studies were performed nationwide[6, 22], one study was conducted in urban areas [13], and one study was conducted in both urban and rural areas [15]. The estimated prevalence was 5.98% (95% CI: 3.50–9.06%), 0.04% (95% CI: 0.00–0.39%) and 2.56% (95% CI: 2.17–2.97%) among studies conducted in rural areas, urban areas and nationwide, respectively. (Table 2).

Prevalence of HBV among the general population based on study period

The prevalence of HBV infection among the general population in Cambodia was also estimated based on the study period. Three studies were conducted before 2005 [13, 21, 23], and six were conducted after 2005 [5, 6, 15, 19, 22, 25]. One study published in 2010 did not specify the samples collection period [30]. The results showed that the prevalence of HBV infection decreased over time: 7.58% (95% CI: 5.31–10.19%) for the studies conducted before 2005 and 3.32% (95% CI: 1.84–5.19%) for the studies conducted after 2005 (p = 0.020). (Table 2).

Genotype distribution

Five studies reported HBV genotype distribution in Cambodia [26,27,28,29,30]. They were published between 1990 and 2020 with a sample size range of 12 to 100. Of the eight well-known genotypes of HBV (A-H), genotypes A, B, and C were identified. The predominant HBV genotype was type C (82.96%). (Fig. 3).

Fig. 3
figure 3

HBV genotype distribution in Cambodia, 1990 and 2020. This figure shows the distribution of HBV genotypes in Cambodia from the studies published between 1990 and 2020. The blue square presented the proportion of genotype in each individual study with the 95% confidence interval. The red diamond represents the pooled proportion of each genotype. N/A: not applicable

Full size image

Publication bias

The Egger test showed no evidence of publication bias, with a p-value = 0.20. The funnel plot also illustrated a distribution of HBV prevalence studies among the general population in Cambodia close to symmetry. (Supplementary Fig. 3).

Discussion

Endemicity of hepatitis B infection is classified into three levels: high (≥ 8% of HBsAg prevalence), intermediate (2–7% of HBsAg prevalence), and low (< 2% of HBsAg prevalence) [31]. Our estimated HBV prevalence of 4.73% (95% CI: 2.75–7.17%) in the Cambodian general population classifies the country among those with intermediate endemicity. This estimate is similar to the previously reported prevalence of 4.39% (95% CI: 3.53%–5.45%) among mothers of 5–7 years old children in the 2017 nationwide study [6]. Compared to neighboring countries at a similar period, our reported HBV prevalence is lower (5.1–6.42% in Thailand, 10.79–11.2% in Vietnam, and 8–8.74% in Laos) [32,33,34,35].

In countries with intermediate HBV endemicity, both horizontal and vertical transmission routes exist, but vertical transmission represents the main transmission mode [31]. Therefore, HBV screening among pregnant women to identify those at risk of transmitting it to their babies, and implementation of prevention measures in childhood can remarkably reduce the spread of the virus and the future occurrence of HCC.

Based on participants’ age, the prevalence of HBV infection among adults (> 15 years old) was about three folds significantly higher than that among children. We believe that the difference was due to a cohort effect. Indeed, all those older than 15 were born before 2005, the year of implementation of the nationwide Hep B vaccine at birth in Cambodia, and most of them had not received the birth dose. Therefore, they were at a higher risk of HBV infection than those born after 2005, especially if they were born to a chronic HBV mother. Correspondingly, by year of study, HBV infection prevalence was higher in studies conducted before 2005 (7.58%) than those conducted after 2005 (3.32%). Health care waste management (HCWM) issued by the Ministry of Health of the Kingdom of Cambodia in July 2008 might have contributed to decreasing HBV prevalence, alongside vaccination programs [36]. These guidelines define all types of health care waste and the requirements for their identification, labeling, and classification. Also, the technical requirements for the segregation, collection, storage, handling, and disposal of waste generated by healthcare facilities are described. The HCWN regulations have certainly contributed to protecting health care workers, waste handlers, and the community from exposure to injury or infection, including hepatitis B. Moreover, disposable devices for invasive procedures (syringes, small surgery kits, ear-piercing, needles) have become more available in the last decade. Therefore, unsafe medical practices such as reusing syringes/needles for multiple patients would spontaneously diminish. In a nutshell, the difference in HBV prevalence among the two cohorts can be explained by the direct and indirect impact of the nationwide Hep B vaccination program, the improvement of clinical hygiene, HCWM, and use of disposable devices in Cambodia.

Our review found a higher prevalence of HBV infection in rural areas than in urban areas. But the included studies conducted in urban areas were performed only on the children population, while the studies conducted in rural areas were performed on both children and adults. Therefore, the lower HBV prevalence in urban areas could result from an imbalance in the study population (Supplementary Fig. 1). However, it is noteworthy that the estimated prevalence of HBV infection among children (≤ 15 years old) was higher in rural areas than in urban areas (3.88% vs 0.04%) (Supplementary Fig. 2). Even though the number of studies in each area was small, this difference might be explained by the Hep B vaccination coverage. It has been reported that the coverage of at least three doses of Hep B vaccine varied by region and was higher in urban areas (91%) than in rural (82%) and remote (64%) areas [15]. Nonetheless, the possibility of different risk factors across the two areas cannot be ruled out. Further studies on socio-behavioral factors affecting HBV transmission in different areas are needed.

We noticed that the prevalence of HBV infection decreased over time. In 2017, Cambodia achieved the national and regional goal of reducing hepatitis B prevalence in children to less than 1% [4]. These are the results of improved clinical hygiene, increased use of disposable products, and expanded coverage of the nationwide Hep B vaccination program since 2005. Twelve years later, Vichit O., et al. reported that 78.4% of children aged 5–7 years received the birth dose of Hep B vaccine, and 92.3% of them received three doses of the pentavalent vaccine [6]. However, only 5.97% of their mothers had ever received the Hep B vaccine [37].

HBV genotypes B and C are predominant in the Asia Pacific region [38]. In our study, all the five studies describing HBV genotypes in Cambodia consistently reported the predominance of genotype C, which is a known factor for HBeAg positivity and risk of HCC [39].

There were some limitations in this study. The inconsistency of diagnostic methods and different test generations might have influenced the estimated prevalence. Also, with the limited access to grey literature in Cambodia, our review was performed among published studies indexed in the four databases searched, which may not be comprehensive. Therefore, the calculated prevalence might be higher/lower than the actual prevalence. However, the results of the Egger test and the funnel plot showed no publication bias. Furthermore, some of the included studies had a small sample size. As a result, the DerSimonian and Laird estimator of the between-study variance might have bias [40,41,42]. The inclusion of some low-grade studies might have affected the pooled prevalence. Moreover, the number of studies reporting HBV genotypes in Cambodia between 1990 and 2020 was small, with limited information on the geographical location. Therefore, HBV genotype distribution by geographical location could not be performed.

To the best of our understanding, this is the first systematic review and meta-analysis of HBV prevalence and its genotype distribution in Cambodia. We followed the strict rules of the PRISMA reporting guidelines. Thus, the results of the present study give an insight into the prevalence of HBV infection in Cambodia. Future studies need to address these limitations to obtain more accurate results.

Conclusion

This systematic review and meta-analysis addressed the variation of HBV prevalence and its genotype distribution in Cambodia. We observed that HBV prevalence decreased over time as a result of the implementation of Hep B vaccine, the improvement of clinical hygiene, and the use of disposable devices. However, the estimated HBV prevalence among the general population indicates an intermediate endemicity level of HBV infection. Therefore, population screening and linkage to care, high vaccination coverage, health promotion, and HBV surveillance are essential to meet the WHO 2030 goal.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Abbreviations

ALT/AST:

Alanine Aminotransferase/Aspartate Aminotransferase

ES:

Effect Size

HBV:

Hepatitis B Virus

HCC:

Hepatocellular Carcinoma

HCV:

Hepatitis C Virus

HCWM:

Health Care Waste Management

PLWHIV:

People Living with HIV

WHO:

World Health Organization

References

  1. World_Health_Organization. Fact sheets: Hepatitis B. Updated 27 July 2020. https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b. Accessed 16 Dec 2020.

  2. World_Health_Organization. WHO releases first-ever global guidance for country validation of viral hepatitis B and C elimination. World Health Organization. Updated June 25, 2021. https://www.who.int/news/item/25-06-2021-who-releases-first-ever-global-guidance-for-country-validation-of-viral-hepatitis-b-and-c-elimination. Accessed 17 Dec 2021.

  3. World_Health_Organization. Hepatitis data and statistics in the Western Pacific. Updated July 23, 2018.  https://www.who.int/westernpacific/health-topics/hepatitis/regional-hepatitis-data. Accessed 16 Dec 2020.

  4. World_Health_Organization. Cambodia achieves national and regional goal for reducing hepatitis B in children. Updated June 8, 2018. https://www.who.int/cambodia/news/detail/08-06-2018-cambodia-achieves-national-and-regional-goal-for-reducing-hepatitis-b-in-children. Accessed 20 Sept 2021.

  5. Fujimoto M, Chuon C, Nagashima S, Yamamoto C, Ko K, Svay S, et al. A seroepidemiological survey of the effect of hepatitis B vaccine and hepatitis B and C virus infections among elementary school students in Siem Reap province. Cambodia Hepatol Res. 2018;48(3):E172–82.

    CAS  PubMed  Google Scholar 

  6. Ork V, Woodring J, Shafiqul Hossain M, Wasley A, Nagashima S, Yamamoto C, et al. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017. Vaccine. 2019;37(35):5059–66.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97–111.

    Article  PubMed  Google Scholar 

  9. Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72(1):39.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178–89.

    Article  PubMed  Google Scholar 

  11. Buchy P, Monchy D, An TT, Srey CT, Tri DV, Son S, et al. Prevalence of hepatitis A, B, C and E virus markers among patients with elevated levels of Alanine aminotransferase and Aspartate aminotransferase in Phnom Penh (Cambodia) and Nha Trang (Central Vietnam). Bull Soc Pathol Exot. 2004;97(3):165–71.

    CAS  PubMed  Google Scholar 

  12. Chassagne F, Rojas Rojas T, Bertani S, Bourdy G, Eav S, Ruiz E, et al. A 13-Year Retrospective Study on Primary Liver Cancer in Cambodia: A Strikingly High Hepatitis C Occurrence among Hepatocellular Carcinoma Cases. Oncology. 2016;91(2):106–16.

    Article  PubMed  Google Scholar 

  13. Chhour YM, Ruble G, Hong R, Minn K, Kdan Y, Sok T, et al. Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children. Emerg Infect Dis. 2002;8(5):485–9.

    Article  PubMed  PubMed Central  Google Scholar 

  14. De Weggheleire A, An S, De Baetselier I, Soeung P, Keath H, So V, et al. A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening. PLoS One. 2017;12(8):e0183530.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Mao B, Patel MK, Hennessey K, Duncan RJ, Wannemuehler K, Soeung SC. Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia. Vaccine. 2013;31(40):4459–64.

    Article  PubMed  Google Scholar 

  16. Narin P, Hamajima N, Kouy S, Hirosawa T, Eav S. Characteristics of liver cancer at Khmer-soviet Friendship Hospital in Phnom Penh. Cambodia Asian Pac J Cancer Prev. 2015;16(1):35–9.

    Article  PubMed  Google Scholar 

  17. Nouhin J, Iwamoto M, Prak S, Dousset JP, Phon K, Heng S, et al. Molecular epidemiology of hepatitis C virus in Cambodia during 2016–2017. Sci Rep. 2019;9(1):7314.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Ohshige K, Morio S, Mizushima S, Kitamura K, Tajima K, Ito A, et al. Cross-sectional study on risk factors of HIV among female commercial sex workers in Cambodia. Epidemiol Infect. 2000;124(1):143–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ol HS, Bjoerkvoll B, Sothy S, Van Heng Y, Hoel H, Husebekk A, et al. Prevalence of hepatitis B and hepatitis C virus infections in potential blood donors in rural Cambodia. Southeast Asian J Trop Med Public Health. 2009;40(5):963–71.

    PubMed  Google Scholar 

  20. Rouet F, Nouhin J, Zheng DP, Roche B, Black A, Prak S, et al. Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014–2015. Clin Infect Dis. 2018;66(11):1733–41.

    Article  CAS  PubMed  Google Scholar 

  21. Sarmati L, Andreoni M, Suligoi B, Bugarini R, Uccella I, Pozio E, et al. Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia. Am J Trop Med Hyg. 2003;68(4):501–2.

    Article  PubMed  Google Scholar 

  22. Soeung SC, Rani M, Huong V, Sarath S, Kimly C, Kohei T. Results from nationwide hepatitis B serosurvey in Cambodia using simple and rapid laboratory test: implications for National Immunization Program. Am J Trop Med Hyg. 2009;81(2):252–7.

    Article  PubMed  Google Scholar 

  23. Thüring EG, Joller-Jemelka HI, Sareth H, Sokhan U, Reth C, Grob P. Prevalence of markers of hepatitis viruses A, B, C and of HIV in healthy individuals and patients of a Cambodian province. Southeast Asian J Trop Med Public Health. 1993;24(2):239–49.

    PubMed  Google Scholar 

  24. van Griensven J, Phirum L, Choun K, Thai S, De Weggheleire A, Lynen L. Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia. PLoS One. 2014;9(2):e88552.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Yamada H, Fujimoto M, Svay S, Lim O, Hok S, Goto N, et al. Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap. Cambodia Hepatol Res. 2015;45(4):480–7.

    Article  PubMed  Google Scholar 

  26. Chuon C, Takahashi K, Matsuo J, Katayama K, Yamamoto C, Ko K, et al. High possibility of hepatocarcinogenesis in HBV genotype C1 infected Cambodians is indicated by 340 HBV C1 full-genomes analysis from GenBank. Sci Rep. 2019;9(1):12186.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Huy TT, Sall AA, Reynes JM, Abe K. Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates in Cambodia. Virus Genes. 2008;36(2):299–305.

    Article  CAS  PubMed  Google Scholar 

  28. Ko K, Takahashi K, Nagashima S, Yamamoto C, Ork V, Sugiyama A, et al. Existence of hepatitis B virus surface protein mutations and other variants: demand for hepatitis B infection control in Cambodia. BMC Infect Dis. 2020;20(1):305.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Srey CT, Ijaz S, Tedder RS, Monchy D. Characterization of hepatitis B surface antigen strains circulating in the Kingdom of Cambodia. J Viral Hepat. 2006;13(1):62–6.

    Article  CAS  PubMed  Google Scholar 

  30. Sa-Nguanmoo P, Tangkijvanich P, Thawornsuk N, Vichaiwattana P, Prianantathavorn K, Theamboonlers A, et al. Molecular epidemiological study of hepatitis B virus among migrant workers from Cambodia, Laos, and Myanmar to Thailand. J Med Virol. 2010;82(8):1341–9.

    Article  PubMed  Google Scholar 

  31. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel SM, Ward JW. Recommendations for identification and public health management of persons with chronic Hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR-8):1–20.

    PubMed  Google Scholar 

  32. Leroi C, Adam P, Khamduang W, Kawilapat S, Ngo-Giang-Huong N, Ongwandee S, et al. Prevalence of chronic hepatitis B virus infection in Thailand: a systematic review and meta-analysis. Int J Infect Dis. 2016;51:36–43.

    Article  PubMed  Google Scholar 

  33. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–55.

    Article  PubMed  Google Scholar 

  34. Thanh PN, Tho NTT, Phu TD, Dai Quang T, Duong NT, Chien VC, et al. Prevalence and factors associated with chronic Hepatitis B infection among adults in the Central Highland. Vietnam AIMS Medical Science. 2020;7(4):337–46.

    Article  Google Scholar 

  35. World_Health_Organization. Lao PDR national seminar to mark World Hepatitis Day 2019. Updated August 29, 2019. https://www.who.int/laos/news/speeches/speech/statement-of-wr-on-world-hepatitis-day-2019. Accessed 26 Mar 2022.

  36. Ministry_of_Health_Cambodia. Healthcare Waste Management Regulation. 2008. https://niph.org.kh/niph/uploads/library/pdf/LD111_11_08_08_Final_HCWM_Regulation_Khmer_2.pdf.

  37. Tanaka J, Ork V, Woodring J, et al. The sero-epidemiological study on the prevalence of hepatitis B among children and mothers in the kingdom of Cambodia, 2016-2017. Japan: Hiroshima University; 2018. p. 36.

  38. Kao JH. Molecular epidemiology of hepatitis B virus. Korean J Intern Med. 2011;26(3):255–61.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Chan HL-Y, Hui AY, Wong ML, Tse AM-L, Hung LC-T, Wong VW-S, et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut. 2004;53(10):1494–8.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Lin L. Bias caused by sampling error in meta-analysis with small sample sizes. PLoS One. 2018;13(9):e0204056.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Böhning D, Malzahn U, Dietz E, Schlattmann P, Viwatwongkasem C, Biggeri A. Some general points in estimating heterogeneity variance with the DerSimonian-Laird estimator. Biostatistics. 2002;3(4):445–57.

    Article  PubMed  Google Scholar 

  42. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This study was financially supported by 1) Ministry of Health Labour and Welfare of Japan (JPMH19HC1001), and 2) Japan Society for the Promotion of Science (JSPS); Fund for the promotion of Joint International Research (Fostering Joint International Research-B; JP18KK0262).

Author information

Authors and Affiliations

  1. Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, 734-8551, Japan

    Bunthen E, Serge Ouoba, Md Razeen Ashraf Hussain, Ko Ko, Shintaro Nagashima, Aya Sugiyama, Tomoyuki Akita & Junko Tanaka

  2. Payment Certification Agency (PCA), Ministry of Health, Phnom Penh, Cambodia

    Bunthen E

  3. Fertility Clinic of Cambodia, Phnom Penh, Cambodia

    Pichetra Ou

  4. Unité de Recherche Clinique de Nanoro (URCN), Institut de Recherche en Sciences de La Santé (IRSS), Nanoro, Bobo-Dioulasso, Burkina Faso

    Serge Ouoba

Authors
  1. Bunthen E
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pichetra Ou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Serge Ouoba
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Md Razeen Ashraf Hussain
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ko Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shintaro Nagashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Aya Sugiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tomoyuki Akita
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Junko Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study concept and design: JT, AS, BE; Conducting the study: JT, BE, PO, TA, AS; Data analysis: BE, TA, PO, SO; Data Interpretation: BE, TA, PO, SO, MRAH, KK, SN; Manuscript development: BE, PO, SO, MRAH, KK, SN, JT; Critical revision for important intellectual content: JT, AS. All authors have read and approved the final version of the manuscript.

Corresponding author

Correspondence to Junko Tanaka.

Ethics declarations

Ethics approval and consent to participate

This is a retrospective study using published data. There were no study interventions. The published data were already anonymized to protect privacy. Therefore, ethics approval was not required for this study.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Supplementary Figure 1.

This figure shown the results of sub-groupanalysis among general population based on study area. The study area wasdivided into three groups, rural areas, urban area and nationwide. The bluesquare presented the prevalent of HBV infection in each individual study with95% confident interval. The red diamond showed the HBV infection pooledprevalent of each population group. Supplementary Figure 2. This figure shown the results of sub-group analysis among children aged equal or less than 15 years old based on study area. The study area was divided into three groups, rural areas, urban area and nationwide. The blue square presented the prevalent of HBV infection in each individual study with 95% confident interval. The red diamond showed the HBV infection pooled prevalent of each population group. Supplementary Figure 3. This figure shown the Funnel plot of arcsine of the estimate HBV infection prevalence by its reverse variance. Each blue dot represents the prevalence of each study. SE, standard error.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

E, B., Ou, P., Ouoba, S. et al. Prevalence and genotype distribution of viral hepatitis B in Cambodia between 1990 and 2020: a systematic review and meta-analysis. Arch Public Health 80, 119 (2022). https://doi.org/10.1186/s13690-022-00880-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13690-022-00880-9

Keywords

Archives of Public Health

ISSN: 2049-3258